We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$116M
AUM Growth
-$1.44M
Cap. Flow
-$1.6M
Cap. Flow %
-1.38%
Top 10 Hldgs %
24.2%
Holding
184
New
25
Increased
26
Reduced
81
Closed
25

Top Buys

Rank Stock Value
1
VLO icon
Valero Energy
VLO
+$1.1M
2
AZN icon
AstraZeneca
AZN
+$748K
3
NVS icon
Novartis
NVS
+$704K
4
AVT icon
Avnet
AVT
+$701K
5
SYNA icon
Synaptics
SYNA
+$698K

Top Sells

Rank Stock Value
1
MLM icon
Martin Marietta Materials
MLM
+$829K
2
TD icon
Toronto Dominion Bank
TD
+$755K
3
PVTB
PrivateBancorp Inc
PVTB
+$677K
4
BMY icon
Bristol-Myers Squibb
BMY
+$664K
5
WMT icon
Walmart Inc
WMT
+$646K

Sector Composition

Rank Sector Weight
1 Healthcare 19.02%
2 Industrials 16.07%
3 Consumer Staples 15.08%
4 Financials 12.64%
5 Consumer Discretionary 12.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OI icon
126
O-I Glass
OI
$1.08B
$301K 0.26%
+16,700
New +$306K
EOG icon
127
EOG Resources
EOG
$70.7B
$300K 0.26%
3,595
– –
DAL icon
128
Delta Air Lines
DAL
$60.1B
$297K 0.26%
+8,150
New +$347K
HON icon
129
Honeywell
HON
$78B
$295K 0.25%
2,823
– –
WM icon
130
Waste Management
WM
$91B
$288K 0.25%
4,350
– –
GIL icon
131
Gildan
GIL
$10.6B
$285K 0.25%
+9,700
New +$289K
WKC icon
132
World Kinect Corp
WKC
$1.86B
$280K 0.24%
+5,900
New +$275K
BNS icon
133
Scotiabank
BNS
$108B
$276K 0.24%
5,625
-124
-2% -$6.09K
GILD icon
134
Gilead Sciences
GILD
$165B
$272K 0.23%
3,265
+175
+6% +$15.5K
HSBC.PRA
135
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
$270K 0.23%
10,400
– –
PX
136
DELISTED
Praxair Inc
PX
$264K 0.23%
2,350
-75
-3% -$8.51K
ESRX
137
DELISTED
Express Scripts Holding Company
ESRX
$262K 0.23%
3,450
-100
-3% -$7.35K
CNBKA
138
DELISTED
Century Bancorp Inc/Mass
CNBKA
$257K 0.22%
6,080
-854
-12% -$35.5K
THRM icon
139
Gentherm
THRM
$1.27B
$255K 0.22%
7,445
-600
-7% -$22.8K
UFI icon
140
UNIFI
UFI
$134M
$246K 0.21%
9,050
– –
RDN icon
141
Radian Group
RDN
$4.91B
$243K 0.21%
23,350
– –
HES
142
DELISTED
Hess
HES
$240K 0.21%
4,000
-300
-7% -$17.4K
VZ icon
143
Verizon
VZ
$196B
$239K 0.21%
4,283
+100
+2% +$5.19K
WMT icon
144
Walmart Inc
WMT
$890B
$229K 0.2%
9,411
-27,900
-75% -$646K
CCL icon
145
Carnival Corporation Ltd
CCL
$39.7B
$225K 0.19%
+5,100
New +$250K
CFG icon
146
Citizens Financial Group
CFG
$30.6B
$217K 0.19%
10,850
– –
HUBB icon
147
Hubbell
HUBB
$27.2B
$216K 0.19%
+2,050
New +$216K
KEY icon
148
KeyCorp
KEY
$24.4B
$211K 0.18%
19,100
-4,200
-18% -$50.1K
PFSI icon
149
PennyMac Financial
PFSI
$4.02B
$211K 0.18%
16,900
-400
-2% -$5.19K
WWAV
150
DELISTED
The WhiteWave Foods Company
WWAV
$207K 0.18%
4,400
-13,050
-75% -$560K
4 5
6
7 8

Similar funds

GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return
FAFN
First Affirmative Financial Network Colorado Springs, Colorado $258M AUM
CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return

New England Research & Management's Q2 2016 Portfolio in Review

As of Q2 2016, New England Research & Management held 184 positions worth $116M, down 1.2% from $118M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

New England Research & Management's Q2 2016 filing shows 25 new, 26 increased, 81 reduced and 25 closed positions. Its largest new stake was AstraZeneca: 12,875 shares worth $777K. The largest sale was Martin Marietta Materials, an estimated $829K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Industrials and Consumer Staples.

  • New England Research & Management's largest Q2 2016 buy was AstraZeneca: 12,875 shares worth $777K.
  • New England Research & Management added most to Valero Energy in Q2 2016, an estimated $1.1M increase.
  • New England Research & Management's biggest Q2 2016 reduction was Bristol-Myers Squibb, cutting an estimated $664K.
  • New England Research & Management fully exited Martin Marietta Materials in Q2 2016, selling an estimated $829K.
  • New England Research & Management's ten largest holdings make up 24% of its $116M portfolio in Q2 2016.
  • New England Research & Management opened 25 new positions and closed 25 in Q2 2016.
  • New England Research & Management's portfolio value fell 1.2% quarter-over-quarter to $116M.

Based on New England Research & Management's 13F filing for Q2 2016, filed 5 Jul 2016.